HERON THERAPEUTICS INC HRTX
ASignal's systematic analysis rates HRTX as Bearish.
Reflects the latest available analysis · analyzed Oct 31, 2026
The case on HRTX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Gross margin above 50% indicating pricing power
- Current ratio above 2 suggesting short-term liquidity strength
- Price near lower Bollinger Band, indicating potential reversal
- Negative MACD histogram and bearish momentum
- High debt-to-equity ratio of 21.48x signaling financial risk
- Negative free cash flow and operating cash flow
- EV/EBITDA at -18.26x due to negative earnings
- Only one news source (Yahoo), low news coverage
- No Reddit mentions, indicating lack of retail interest
See the full verdict on HRTX
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HRTX
Most investors never get a second opinion, let alone several. ASignal runs HRTX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.